Afon Technology, a medtech company in Wales, aims to transform diabetes management with its non-invasive glucose monitoring device, GlucowearTM. The company recently partnered with Sony UK Technology Centre for manufacturing, a key step towards bringing the device to market.
Adrian Overall, CEO and Founder of CloudStratex, discusses how the UK government has historically struggled to digitally transform itself and how it can be best be addressed to ensure value for the taxpayer.
A study, published in Nature Neuroscience, finds that pain can block how dopamine functions - meaning that the negative effects of pain can theoretically be reversed.